| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |